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Elucidating the mechanisms by which pancreatic β-cells couple glucose sensing to insulin secretion, a vital process in energy homeostasis, is of prime importance. Although ATP production is considered the main mitochondrial signal, detailed studies show that insulin secretion cannot be restricted to ATP synthesis, and numerous experimental clues show that additional mitochondrial factors involved in glucose-secretion coupling are necessary, although not yet identified ([@r1]).

Transient increases in glucose metabolism generate NADH and FADH~2~, leading rapidly to increased superoxide anion (O~2~^·^) production; obligatorily associated with the respiratory chain function, superoxide anion will be converted into H~2~O~2~ ([@r2]). This production of mitochondrial reactive oxygen species (mROS)---transient because H~2~O~2~-inactivating enzymes rapidly quench it before a damage to the physiological conditions of the cell occurs---is now recognized as an intracellular messenger ([@r3],[@r4]). These features make mROS a good candidate for rapidly regulating pathways that depend directly on metabolic fluxes. Based on such a view, we recently demonstrated that mROS production is required for hypothalamic glucose and lipid sensing ([@r5],[@r6]). These results lead us to speculate that O~2~^·^ might operate more generally in nutrient-sensitive cells and also to look for the role of mROS as a signal involved in glucose-stimulated insulin secretion (GSIS). Recently, a study revealed that H~2~O~2~ is effectively a signal of GSIS ([@r7]). Here, we provide clues that glucose-induced mitochondrial O~2~^·^ production is an obligatory stimulus for insulin secretion.

RESEARCH DESIGN AND METHODS
===========================

Male Wistar rats, weighting 250--300 g, were maintained in animal quarters at a constant temperature (21--23°C) and with a 12-h light/12-h dark cycle. Food and water were available ad libitum. All rats were treated in accordance with European Community guidelines, and our local institution approved the experimentation. Pharmacological agents were all purchased from Sigma-Aldrich, except carbonyl cyanide *m*-chlorophenylhydrazone (CCCP), which was obtained from Calbiochem.

Islet isolation.
----------------

Rats were anesthetized using pentobarbital (4 mg/100 g body wt i.p.; Sanofi Santé Animale, Libourne, France). Islets of Langerhans were isolated after collagenase digestion of the pancreas, as previously described ([@r8]). Briefly, the pancreatic duct was ligated distally and injected with an ice-chilled solution of collagenase (Type V collagenase; Sigma) and 5.5 mmol/l glucose in Hank\'s balanced salt solution (HBSS; 137 mmol/l NaCl, 5.36 mmol/l KCl, 4.17 mmol/l NaHCO~3~, 0.88 mmol/l MgSO~4~, 0.44 mmol/l KH~2~PO~4~, 0.34 mmol/l Na~2~HPO~4~, 1.27 mmol/l CaCl~2~, 10 mmol/l HEPES, and 0.5% BSA). The pancreas was removed and incubated for 9 min at 37°C. The suspension was repeatedly passed through a 14-gauge needle. After several centrifugations and resuspensions in ice-cold HBSS, the dispersed pancreas was filtered through a 500-μm screen. The filtrate was pelleted and resuspended in 20 ml Histopaque 1077 (Sigma), on the top of which 20 ml HBSS was carefully layered. After 20 min of centrifugation at 2,500 rpm at room temperature, the islets were recovered from the interface and washed twice in HBSS. The islets were immediately used for static incubations or perifusion experiments.

Insulin release, ATP, NADH, and ROS evaluations under static incubation.
------------------------------------------------------------------------

Insulin release was measured on the islet batches in the supernatant using radioimmunoassay. Groups of 60--80 islets were first preincubated for 60 min at 37°C in silicone-coated glass tubes, in 1 ml Krebs-Ringer bicarbonate HEPES buffer (KRBH) buffer supplemented with 5 mg/ml BSA (fraction V; Sigma) and 2.8 mmol/l glucose. For the first 15 min of preincubation, the tubes were gassed with a mixture of O~2~:CO~2~ (95%:5%). Over the preincubation period, the medium was eliminated and replaced with 1 ml KRBH-BSA medium \[KRBH buffer (140 mmol/l NaCl, 3.6 mmol/l KCl, 0.5 mmol/l NaH~2~PO~4~, 0.5 mmol/l MgSO~4~, 2 mmol/l NaHCO~3~, 1.5 mmol/l CaCl~2~, and 10 mmol/l HEPES) and 1% BSA (fraction V; Sigma)\] containing the different glucose concentrations and/or pharmacological agents 1 mmol/l trolox, 100 μmol/l rotenone, 20 μmol/l antimycin, 1 mmol/l glutathione ethylester, and 1 μmol/l CCCP. Rotenone and antimycin partially block the electron transfer in the mitochondrial chain (depending on concentration), favoring the reaction with molecular O~2~, and then increasing anion superoxide formation, which is itself being rapidly converted into H~2~O~2~ (via the mitochondrial manganese superoxide dismutase \[MnSOD\]). The islets were further incubated for 30 min at 37°C. At the end of this period, the medium was stored at −20°C until assayed for insulin, except for resecretion tests. The islets were sonicated, and ATP and NADH contents were respectively determined using a bioluminescent kit (Sigma-Aldrich) and a spectrophotometer to measure NADH through the absorbance at 340 nm. In experiments to determine intracellular ROS, islets were loaded with a fluorescent probe that corresponds to intracellular H~2~O~2~ increase, because the probe used (CM-H~2~DCFDA) is a classical H~2~O~2~ marker. The incubation was conducted as previously described ([@r6]). At the end of the experiments, islets were rinsed and disrupted using sterile water. After a 5-min centrifugation (3,000 × *g*), islet supernatants containing the oxidized product fluorescing due to ROS were analyzed as previously described ([@r6]).

Evaluation of insulin release during perifusion experiments.
------------------------------------------------------------

Kinetics of insulin release in vitro were studied using the perifusion procedure already described ([@r8]). Four columns were run at the same time, each containing 85--120 freshly isolated islets of Langerhans. The perifusion medium containing the basal buffer \[2.8 mmol/l glucose in KRBH containing 140 mmol/l NaCl, 3.6 mmol/l KCl, 0.5 mmol/l NaH~2~PO~4~, 0.5 mmol/l MgSO~4~, 2 mmol/l NaHCO~3~, 1.5 mmol/l CaCl~2~, 10 mmol/l HEPES, and 1% BSA (fraction V; Sigma)\] was supplemented with a high glucose concentration (16.7 mmol/l) and/or the pharmacological agents 1 mmol/l trolox (a vitamin E analog, involved in the synergic regeneration of antioxidant defenses, such as reduced glutathione, as well as a powerful scavenger of peroxide radicals in membranes) and 100 μmol/l rotenone as needed. The perifusion fluid was collected at 1-min intervals and kept on ice until the end of the experiment. Fractions collected were stored at −20°C until assayed for insulin.

Measurements of islet intracellular free calcium concentration.
---------------------------------------------------------------

Freshly isolated islets were loaded for 1 h with 5 μmol/l Fura-2/AM at 37°C in KRBH containing 115 mmol/l NaCl, 5 mmol/l KCl, 24 mmol/l NaHCO~3~, 1 mmol/l CaCl~2~, 1 mmol/l MgCl~2~, and 5.5 mmol/l glucose and 5 mg/ml BSA. After loading, eight islets at a time were allowed to attach onto a polylysine-treated coverglass transferred to a perifusion chamber placed on the stage of an inverted fluorescent microscope (Nikon Diaphot, Champigny sur Marne, France). Canulas feeding into the chamber were connected to a peristaltic pump and allowed a continuous superfusion of the islets at a flow rate of 1 ml/min with a 25 mmol/l HEPES-buffered medium maintained at 37°C containing 125 mmol/l NaCl, 5.9 mmol/l KCl, 1.28 mmol/l CaCl~2~, 1.2 mmol/l MgCl~2~, 5.5 mmol/l glucose, and 1 mg/ml BSA. Intracellular free Ca^2+^ concentration (\[Ca^2+^\]~i~) was determined as previously described ([@r9],[@r10]). Briefly, a selected area of the islets was excited at 340 and 380 nm alternatively (every 2 s), and the fluorescence intensity emitted at 510 nm was measured by using a Photoscan II microfluorometer (Photon Technology International, Biotek Kontron, St. Quentin Yvelines, France). The measurements of successive 340/380 fluorescence ratios (R) reflect the cytosolic free calcium concentration that is abbreviated as follows: \[Ca^2+^\]~i~. Finally, calcium origin was investigated by imaging intracellular Ca^2+^ activity in presence of 1 μmol/l thapsigargin or 1 mmol/l EGTA. Effects of ROS on depolarization were done in presence of the antioxidant trolox (1 mmol/l) by stimulating islets with 30 mmol/l KCl. Before islet measurement, background fluorescence was recorded for both wavelengths in areas devoid of islets, and the data were subtracted from the corresponding measurements of fura-2--loaded islets.

Insulin resecretion test.
-------------------------

After antimycin or rotenone exposition (static condition) for 30 min, islets were replaced for 30 min in 5.5 mmol/l glucose, insulin was measured, and then islets were rinsed and re-exposed to 16.7 mmol/l glucose for the same lapse of time; de novo insulin secretion was evaluated on supernatants.

Insulin radioimmunoassay.
-------------------------

Insulin was measured by means of a radioimmunoassay kit (Cis-Bio International, Gif-sur-Yvette, France) using ^125^I-labeled porcine insulin tracer and tube coated with anti-porcine guinea pig antiserum. Rat insulin standard was obtained from Linco Research (St. Charles, MO). The lower limit of the assays was 75 pmol/l with a variation coefficient of 6% within the assays and of 8% between the assays.

Lipid peroxidation determinations.
----------------------------------

Hydroperoxides in biological samples were estimated using the Lipid Hydroperoxide Assay kit (Cayman; Alexis Biochemicals). This method is based on lipid extraction into chloroform, eliminating interference caused by hydrogen peroxide or endogenous ferric ions.

Statistical analysis.
---------------------

Values are expressed as means ± SE. The statistical significance of differences between two groups was determined by Student\'s *t* test, and multiple comparisons were made by ANOVA followed by Student-Newman-Keuls test. For the regressions, a Pearson correlation matrix using SYSTAT software was used, followed by a matrix of Bonferroni probabilities.

RESULTS
=======

Glucose induces ROS production in isolated rat islets.
------------------------------------------------------

A glucose challenge (16.7 mmol/l) during 30-min incubation triggered a threefold increase of ROS fluorescence as shown in [Fig. 1*A*](#f1){ref-type="fig"}. This ROS production was accompanied by a classical GSIS ([Fig. 1*B*](#f1){ref-type="fig"}). We then investigated whether a causal link exists between these two events by quenching ROS rise using an antioxidant. As expected, ROS production was completely abolished by trolox, a vitamin E analog ([Fig. 1*A*](#f1){ref-type="fig"}). Strikingly, this was associated with a complete blunting of GSIS, suggesting the involvement of ROS in GSIS ([Fig. 1*B*](#f1){ref-type="fig"}). To confirm these data, we performed perifusion experiments, which allow a dynamic view of insulin secretion. As was the case previously, the presence of the antioxidant induced a pronounced and significant reduction of GSIS ([Fig. 1*C*](#f1){ref-type="fig"}). We then investigated whether a dose response might be established between ROS production and insulin secretion. This was achieved in static incubation by gradual antioxidant levels to modulate ROS production under GSIS ([Fig. 1*D* and *E*](#f1){ref-type="fig"}). Under these conditions, the regression linking ROS production to insulin secretion (*r* = 0.899) was highly significant (*P* \< 0.001; [Fig. 1*F*](#f1){ref-type="fig"}). Moreover, kinetics of both ROS production and insulin secretion were measured under GSIS and revealed the ROS elevation shown at 5 min coincided with the start of insulin secretion under static conditions. A plateau was maintained for both ROS production and insulin secretion during the 30 min that lasted the experiment ([Fig. 2*A* and *B*](#f2){ref-type="fig"}). Altogether, these results indicated that ROS was produced under acute glucose stimulation and was required for insulin secretion. Moreover insulin was dose dependently released, reinforcing the fact that ROS could be an important part of the in GSIS signaling.

mROS mimic GSIS.
----------------

To test whether mROS have the ability to mimic GSIS, specific mitochondrial blockers that increase mROS production were used. Rotenone and antimycin, complex I and III inhibitors, respectively, were added to the 30-min static incubation with no glucose challenge in basal glucose condition (5.5 mmol/l). The concentrations (100 μmol/l rotenone and 20 μmol/l antimycin) were chosen to mimic a similar ROS production to that obtained with a 16.7 mmol/l glucose stimulus ([Fig. 3*A*](#f3){ref-type="fig"}). Trolox (1 mmol/l) or 1 mmol/l glutathione reduced ethyl ester cotreatment blunted the ROS fluorescence ([Fig. 3*A*](#f3){ref-type="fig"}) and the insulin release ([Fig. 3*B*](#f3){ref-type="fig"}). To assess this response in a dynamic model, perifusion experiments were also conducted. The presence of the mitochondrial blocker rotenone perfectly mimicked GSIS ([Fig. 3*C*](#f3){ref-type="fig"}), which was significantly reduced in the presence of the antioxidant trolox ([Fig. 3*C*](#f3){ref-type="fig"}). To test our hypothesis in static incubation, we coadministered an antioxidant in a dose response--dependent manner. It consequently diminished ROS production ([Fig. 3*D* and *E*](#f3){ref-type="fig"}). ROS production was clearly correlated to insulin secretion (*r* = 0.883), and the regression was highly significant (*P* \< 0.001; [Fig. 3*F*](#f3){ref-type="fig"}). To confirm the mitochondrial origin of glucose-induced ROS, cells were cotreated with 16.7 mmol/l glucose and the mild uncoupler CCCP (1 μmol/l), which makes it possible to block the ATP rise without decreasing its level ([@r11]). This uncoupler accelerates electron transit by dissipating the H^+^ gradient, decreasing the probability of the electrons reacting with oxygen and thus leading to the complete abrogation of ROS fluorescence as shown in [Fig. 3*A*](#f3){ref-type="fig"}. In this case, insulin secretion was completely blunted ([Fig. 3*B*](#f3){ref-type="fig"}). Finally, the effects of rotenone and antimycin in the presence of 16.7 mmol/l glucose had been tested: They increased the ROS production and insulin secretion more efficiently than 16.7 mmol/l glucose alone or mitochondrial blockers alone (data not shown). These results suggest that increasing glucose to 16.7 mmol/l (i.e., electron donors) while partially inhibiting the mitochondrial respiration (slowing down the electron transit) led to the greatest ROS production, finally increasing insulin secretion.

NADH and ATP increases are not necessary for mROS-induced insulin secretion.
----------------------------------------------------------------------------

The results presented in [Fig. 1](#f1){ref-type="fig"} suggested that quenching ROS was strikingly enough to blunt insulin secretion. Because ATP and NADH---two crucial products of glucose metabolism and respiration---have been considered as main cellular triggers for insulin secretion, we undertook a last set of experiments to definitively rule out their involvement. As shown in [Fig. 4*C* and *D*](#f4){ref-type="fig"}, although both ATP and NADH were highly significantly increased, insulin secretion was completely abolished when adding antioxidant as previously reported. In this case, only ROS enhancement was completely blunted ([Fig. 4*A*](#f4){ref-type="fig"}). In the reverse experiment, using mitochondrial blocker 100 μmol/l rotenone, a concentration that did not modify ATP and NADH concentrations ([Fig. 4*C* and *D*](#f4){ref-type="fig"}) but ensured mROS production ([Fig. 4*A*](#f4){ref-type="fig"}), showed that insulin secretion was still stimulated ([Fig. 4*B*](#f4){ref-type="fig"}). In these experiments, it is noteworthy that insulin secretion was achieved with almost identical levels of ROS fluorescence produced either by 16.7 mmol/l glucose or by rotenone, regardless of the high or basal ATP and NADH levels ([Fig. 4*A*--*D*](#f4){ref-type="fig"}). Moreover, no correlation was observed between ATP and NADH levels and insulin secretion. These complementary results strongly suggest that mROS are robust stimulators of insulin secretion independently of these other products linked to glucose metabolism.

Effect of quenching ROS production on intracellular calcium profiles after glucose, mitochondrial blocker, or KCl treatment.
----------------------------------------------------------------------------------------------------------------------------

Switching the extracellular glucose concentration from 5 to 16.7 mmol/l led to an increase in \[Ca^2+^\]~i~. The subsequent addition of 1 mmol/l trolox led to a marked fall in \[Ca^2+^\]~i~ to basal level in the following 5 min, suggesting that ROS quenching led to impaired \[Ca^2+^\]~i~ mobilization ([Fig. 5*A*](#f5){ref-type="fig"}). Switching the extracellular glucose concentration from 5 mmol/l to 5 mmol/l plus 100 μmol/l rotenone first led to a transient fall in \[Ca^2+^\]~i~ in the first 8 min, followed by a large sustained increase ([Fig. 5*B*](#f5){ref-type="fig"}). The addition of the antioxidant trolox (1 mmol/l) to rotenone completely abolished the \[Ca^2+^\]~i~ mobilization ([Fig. 5*B*](#f5){ref-type="fig"}), showing that mROS production might importantly serve as signals mediating the necessary Ca^2+^ recruitment for insulin secretion. Finally, [Fig. 5*C* and *D*](#f5){ref-type="fig"} show one representative example of three experiments for the \[Ca^2+^\]~i~ mobilization under either 1 mmol/l EGTA (chelating extracellular Ca^2+^ ions) or 1 μmol/l thapsigargin (irreversible inhibition of Ca^2+^ pumps from intracellular stores). Increasing the glucose concentration or adding rotenone first triggered a typical biphasic response; second, the presence of EGTA (calcium-free medium) resulted in a profound decrease of fluorescence fura-2 ratio 340:380, i.e., intracellular calcium mobilization, for both glucose and rotenone, suggesting the calcium might be mainly of extracellular origin ([Fig. 5*C*](#f5){ref-type="fig"}). [Figure 5*D*](#f5){ref-type="fig"} shows the complementary experiment using thapsigargin, which did not suppress the massive increase of \[Ca^2+^\]~i~, whatever the stimulus, glucose or rotenone. However, the typical biphasic rise disappeared in both cases, emphasizing that the first peak might required calcium of intracellular origin. In the next experiment, we tested whether the ROS scavenger trolox (1 mmol/l) would abrogate the calcium effect of KCl. It had no inhibitory effect on KCl-induced \[Ca^2+^\]~i~ mobilization ([Fig. 5*E*](#f5){ref-type="fig"}).

No toxic effects are present in the model used.
-----------------------------------------------

To rule out a putative damaging effect on membrane integrity due to peroxidation and a nonspecific oxidative stress of ROS, lipid peroxidation was evaluated. Hydroperoxide measurements were conducted on glucose and pharmacologically treated islets. No difference in peroxidation in the pharmacologically treated groups compared with glucose was observed ([Fig. 6*A*](#f6){ref-type="fig"}). To definitively exclude a toxic effect, β-cells previously treated with the mitochondrial blockers for 30 min were replaced in a fresh medium, and insulin was reevaluated before and after a glucose challenge. Under these conditions, only a slight insulin release was detected in the fresh medium under basal conditions, and the ability of glucose to stimulate insulin secretion was totally maintained after the pharmacological treatments ([Fig. 6*B*](#f6){ref-type="fig"}). Altogether, these results exclude the possibility of damaging effects of rotenone or antimycin on islets.

DISCUSSION
==========

It is now accepted that small fluctuations in the steady-state concentration of ROS may play a role in intracellular signaling ([@r3],[@r12]). Their pivotal role in nutrient sensing is beginning to be considered in the literature since we highlighted their requirement in hypothalamic glucose and lipid sensing ([@r5],[@r6]). Here, we expand the question to the gold standard, and the main glucose-sensitive cell type, the pancreatic β-cells. The present results undoubtedly demonstrate that glucose-induced mitochondrial ROS production is an obligatory stimulus for insulin secretion.

In cells, mitochondria are the main source of oxidants. Transient-accelerated electron transport on glucose stimulation generates an H~2~O~2~ burst in many cell types, including the β-cells ([@r13]). Metabolism of substrates leads to reduced formation of equivalents (NADH and FADH~2~) that predispose to increased mROS through a direct effect on the electron-transfer chain ([@r14]). Preceding studies point to the crucial role of H~2~O~2~, which either acts as a transduction signal, normally coupling glucose metabolism to insulin secretion, or interrupts it depending on its concentration ([@r7],[@r15]--[@r17]).

In this study, the pharmacological approach was highly justified because transient, moderate, and reversible mROS production was required ([@r11]). Currently, no genetic construction, even through a conditional control, permits this fine regulation. In this study, we not only found that insulin is released in a mROS dose-dependent fashion but also that mROS are absolutely required for the secretion, using different and complementary pharmacological manipulations. Our results are coherent and convergent, they moreover are consistent with those of Collins and colleagues ([@r7]), who demonstrated that glucose increases intracellular accumulation of H~2~O~2~, stimulating insulin secretion in both isolated mouse islets and INS-1(832/13) cells. These results enhance the emerging view that glucose induces a transient and moderate H~2~O~2~ production in β-cells. This light production is made possible because a fine adapted system makes it possible to regulate the process (antioxidant defenses) ([@r7]). The discrepancies observed in the levels of ROS (either increase or decrease) in β-cells exposed to glucose reported in numerous studies ([@r15],[@r18],[@r19]) might be explained by the different exposure times and glucose-culture conditions; it now appears clearly that cyclic ROS production occurs in a time-dependent manner ([@r7]). One of the regulating systems operates through the nucleotide nicotinamide transhydrogenase, rapidly and actively regenerating redox balance through the supply of NADPH, which simultaneously dissipates the proton gradient ([@r20]). The light and necessary production of ROS for insulin secretion during glucose exposure might rapidly become inadequate when time exposure is no longer controlled, due to the unbalance of the redox-status regeneration, a process that is exacerbated in culture conditions.

The present data clearly point out the importance of ROS from mitochondrial origin. First, mitochondrial ROS mimic the glucose effect. Using mitochondrial blockers that increase mROS at a level similar to that of glucose, insulin secretion was identical to that produced by glucose. Second, no extramitochondrial ROS was detected in glucose and CCCP-cotreated β-cells. This compound increases respiration and diminishes mROS generation. If glucose has the ability to induce ROS production independently of the mitochondria, it might be detected in a condition that only abolishes mitochondrial ROS production (CCCP). This means that ROS produced in the time course of glucose metabolism might be solely due to mitochondria in our detection conditions. It strongly suggests that mROS are robust stimulators of insulin secretion independently of other products linked to glucose metabolism, such as NADH or ATP. Thus, even in the presence of an NADH or ATP rise, GSIS was systematically blunted when ROS production was abolished. Unfortunately, NADPH, which is a potential mediator of GSIS, was not detectable in our experimental conditions. We cannot exclude its level changed by the manipulations used here, maybe independently of ROS.

Mitochondrial blockers triggering insulin release in our study are in contradiction with the results of Collins and colleagues ([@r7]), who conclude that the ROS might not be of mitochondrial origin. The difference is the concentrations we used, and as a result, the sole difference is based on ATP levels that were unchanged in our model but downregulated in their study. The downregulation of ATP content suggests a strong inhibition of oxidative phosphorylation and might explain the discrepancies between the two studies. The additive experiments on \[Ca^2+^\]~i~ suggest mROS production being of importance, because the addition of the antioxidant trolox to either glucose or rotenone completely abolished the Ca^2+^ mobilization. The results of [Fig. 5*C* and *D*](#f5){ref-type="fig"} suggest mROS are important for the biphasic effect on \[Ca^2+^\]~i~ because they totally mimicked the Ca^2+^ mobilization profile seen with glucose. The exploration of the calcium origin suggests the first peak of Ca^2+^ might be of intracellular origin even through the second massive increase appears to be of extracellular one. These results are in concordance with part of the study of Krippeit-Drews et al. ([@r17]) who had extensively studied the origin of Ca^2+^ under a concentrated H~2~O~2~ stimulus. Whether the Ca^2+^ influx might be due to ATP-sensitive K^+^ channel (K~ATP~ channel)-induced depolarization was undertaken in this study. In this case, H~2~O~2~ caused the opening of the channel (the sulfonylurea tolbutamide was able to reverse the effect), and the sustained extracellular Ca^2+^ influx was shown to be due to a direct activation of [l]{.smallcaps}-type Ca^2+^ channels in mouse β-cells ([@r21]--[@r23]) and recently in dopamine neurons ([@r24]). These results are not in favor of the participation of the K~ATP~ channels in the second sustained increase of \[Ca^2+^\]~i~. Moreover, even if ATP levels were critical in these studies, here, the pharmacological doses of rotenone or antimycin A used were without effect on ATP levels when compared with glucose controls (5.5 mmol/l).

The β-cell depolarization is a crucial event to activate the insulin exocytotic machinery in the early phase of GSIS, and that is the reason why the ROS dependence of depolarization-stimulated Ca^2+^ mobilization was investigated. Our results indicate that mROS-stimulated insulin secretion is an extracellular Ca^2+^-dependent process, suggesting that mROS may be involved in Ca^2+^ influx. In contrast, the evidence that the exogenous antioxidant trolox does not inhibit KCl-induced \[Ca^2+^\]~i~ increase suggests that the voltage pathway works independently of the mROS pathway. These last results are in perfect concordance with those of Collins and colleagues, who did not detect an inhibition of the antioxidants on KCl-induced insulin release. Our results, combined with those of Collins and colleagues, reinforce the idea that mROS belong to the essential coupling factors for stimulating insulin secretion.

Moreover, in our experiments, putative toxic effects can be ruled out; both results of lipid peroxidation and functional tests (GSIS) were in keeping with intact islet preservation. These data support that mROS signaling is of prime importance, although the underlying mechanism(s) leading to insulin secretion is(are) far from being identified.

Strikingly, one is led to think that the classical ATP elevation-induced K~ATP~ closure is not as determinant as has been suggested. Different putative targets might be involved, linking mROS to insulin production. First, the mitochondria itself: mitochondrial Ca^2+^ rise is in part H~2~O~2~ sensitive and absolutely required for insulin secretion ([@r16],[@r17]). Second, the channels, which are involved in membrane depolarization ([@r25]). For example, transient receptor potential channels may also be potential targets because many of them are H~2~O~2~ sensitive ([@r26]--[@r31]).

Altogether, these data point to the complex involvement of mitochondrial metabolism in GSIS. Moreover, the consensual model of ATP as a coupling factor of nutrient-induced insulin secretion is no longer as evident as previously accepted. Finally, our findings support the idea that mROS are obligatory signaling pathways of GSIS. The mROS appear as the necessary balanced signal between NADH supply on one hand and the ATP production on the other hand. The understanding of this signaling might be of prime importance in nutritional care of energy balance and health.
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![Glucose induces ROS production in isolated rat islets. *A*: Glucose challenge (16.7 mmol/l) in a 30-min static incubation triggered a threefold increase in ROS fluorescence. *B*: ROS production was accompanied by a classical GSIS. Quenching ROS by trolox completely blunted GSIS. *A* and *B*: Three independent experiments, *n* = 6 per group; \*\*\**P* \< 0.001, glucose 5.5 vs. 16.7 mmol/l; \#\#\#*P* \< 0.001, glucose 16.7 vs. 16.7 mmol/l+trolox. *C*: Dynamic experiments using perifusion demonstrating the antioxidant-induced reduction of GSIS. Three independent experiments, *P* \< 0.001 between vehicle and treated groups and between 16.7 mmol/l glucose vs. 16.7 mmol/l glucose + trolox. *D* and *E*: Modulation of glucose-induced ROS production and GSIS by gradual antioxidant doses. Three independent experiments, *n* = 6 per group; \*\**P* \< 0.01 or \*\*\**P* \< 0.001, 16.7 mmol/l glucose + 1 nmol/l trolox vs. 16.7 mmol/l glucose + 1 μmol/l trolox; \#\#*P* \< 0.01 or \#\#\# *P* \< 0.001, 16.7 mmol/l glucose + 1 μmol/l trolox vs. 16.7 mmol/l glucose + 1 mmol/l trolox. *F*: In these conditions, the regression linking ROS production to insulin secretion (*r* = 0.899) was highly significant *P* \< 0.001. A.U., arbitrary unit.](zdb0030956550001){#f1}

![ROS kinetics paralleled insulin secretion in GSIS. *A*: Intracellular H~2~O~2~ production measured with H~2~-DCFDA probe. Freshly isolated islets on 5.5 mmol/l glucose before time 0 were treated with 16.7 mmol/l glucose the lasting 30 min. ROS production appeared maximally and reached a plateau at 5 min. *B*: Insulin secretion immediately followed this ROS production and shared a similar profile.](zdb0030956550002){#f2}

![mROS mimic GSIS in β-cells islets. *A*: Effect of treatments on intracellular H~2~O~2~ production measured with H~2~-DCFDA probe. Treatments were as follows: 100 μmol/l rotenone or 20 μmol/l antimycin, inhibitors of complexes I and III, respectively, added to the 30-min static incubation in 5.5 mmol/l glucose; 1 mmol/l trolox or 1 mmol/l glutathione reduced ethyl ester (GE) cotreatment with 16.7 mmol/l glucose or rotenone (rot) or antimycin (ant); 16.7 mmol/l glucose coadministrated with the uncoupler CCCP. *C*: Insulin release measurement in the same conditions. *A* and *C*: Three independent experiments, *n* = 6 per group. \*\*\**P* \< 0.001, glucose 5.5 vs. 16.7 mmol/l, vs. 5.5 mmol/l glucose + rot or 5.5 mmol/l glucose + ant; \#\#\#*P* \< 0.001, 5.5 mmol/l glucose + rot vs. 5.5 mmol/l glucose + rot + trolox or glutathione ethyl ester (GE); §§§*P* \< 0.001, 5.5 mmol/l glucose + ant vs. 5.5 mmol/l glucose + ant + trolox or glutathione ethyl ester (GE); ‡‡‡*P* \< 0.001, 16.7 mmol/l glucose vs. 16.7 mmol/l glucose + CCCP. *E*: Dynamic insulin secretion using perifusion model under rotenone alone or in presence of the antioxidant trolox. Three independent experiments, with one perifused column per case, *P* \< 0.001 between vehicle and treated groups and between rotenone vs. rotenone + trolox. *B* and *D*: Modulation of rotenone-induced ROS production and GSIS by gradual antioxidant doses. ROS-dependent response might be established with insulin secretion in static incubation. Three independent experiments, *n* = 6 per group; \*\*\**P* \< 0.001, rotenone + 1 nmol/l trolox vs. rotenone + 1 μmol/l trolox; \#\#\#*P* \< 0.001, rotenone + 1 μmol/l trolox vs. rotenone + 1 mmol/l trolox. *F*: In these conditions, the regression linking ROS production to insulin secretion (*r* = 0.883) was highly significant *P* \< 0.001. ⋄, vehicle; ♦, glucose 16.7 mM; ▴, rotenone; □, rotenone + trolox.](zdb0030956550003){#f3}

![NADH and ATP increases are not necessary for mROS-induced insulin secretion. Ratio of either ROS production as measured with H~2~-DCFDA (*A*), NADH (*B*), insulin secretion (*C*), or ATP (*D*) compared with basal condition (5.5 mmol/l glucose) in three independent experiments, *n* = 4 per group. *A* and *C*: Static islet incubation for 30 min in 16.7 mmol/l glucose cotreated with trolox abolished ROS production and blunted insulin secretion; \*\*\**P* \< 0.001, glucose 16.7 vs. 5.5 mmol/l; \#\#\#*P* \< 0.001, 16.7 mmol/l glucose + trolox vs. 16.7 mmol/l glucose alone. *B* and *D*: Both NADH and ATP were increased, although insulin secretion was abolished when ROS were blunted; \**P* \< 0.05 or \*\**P* \< 0.001, 16.7 mmol/l glucose + trolox vs. 16.7 mmol/l glucose alone. Conversely, 100 μmol/l rotenone (rot) stimulated ROS production and insulin secretion (*A* and *C*), independently of NADH or ATP (*B* and *D*), which were unchanged compared with controls. \*\*\**P* \< 0.001, 5.5 mmol/l glucose + rotenone vs. 5.5 mmol/l glucose; §§§*P* \< 0.001 or §*P* \< 0.05, 5.5 mmol/l glucose + rotenone vs. 5.5 mmol/l glucose + rotenone + trolox.](zdb0030956550004){#f4}

![Intracellular calcium profiles after glucose, mitochondrial blocker, or KCl treatment. *A*: Intracellular calcium expressed as the ratio of fura-2 probe fluorescence (340 nm/380 nm) from basal conditions (5 mmol/l glucose) to 16.7 mmol/l glucose. Addition of the antioxidant trolox significantly reverses the \[Ca^2+^\]~i~ mobilization classically observed with glucose concentration increase. *C*: The experiment was repeated except that instead of raising glucose, 100 μmol/l rotenone was added to islets. Addition of rotenone first led to a transient fall in \[Ca^2+^\]~i~ the first 8 min, followed by a large and sustained increase. *B*: Investigation of calcium origin using 1 mmol/l EGTA after removal of Ca^2+^ from the extracellular bath solution. Increasing the glucose concentration or adding rotenone first triggered a typical biphasic response, and the presence of EGTA resulted in a profound decrease of fluorescence fura-2 ratio 340:380 for both glucose and rotenone. *D*: Investigation of calcium origin using 1 μmol/l thapsigargin in islets treated with either 16.7 mmol/l glucose or 100 μmol/l rotenone did not suppress the massive increase of \[Ca^2+^\]~i~. The experiment shown is representative of three (glucose and mitochondrial blockers) or two (KCl) with similar results.](zdb0030956550005){#f5}

![Islet preservation under the different mitochondrial treatments. *A*: To exclude a damaging and nonspecific oxidative stress, lipid peroxidation was evaluated. Hydroperoxides were evaluated on islets treated in static incubation for 30 min with 100 μmol/l rotenone, 1 μmol/l CCCP, or 20 μmol/l antimycine compared with basal conditions, 5.5 mmol/l glucose. No difference in these groups compared with glucose was observed. *B*: Insulin resecretion after the 100 μmol/l rotenone or 20 μmol/l antimycin treatment consisted to expose islets to GSIS after they were stimulated with the mitochondrial blockers for 30 min and insulin was measured in the milieu. They were replaced in basal glucose (5.5 mmol/l) for 30 min further, and insulin was reevaluated before a GSIS was done. In these conditions, insulin release was absent in the milieu in basal conditions, and the ability of glucose to restimulate insulin secretion was totally maintained after the pharmacological treatments. Three independent experiments, *n* = 6; \*\*\**P* \< 0.001, glucose 16.7 vs. 5.5 mmol/l. Bars represent SE in all figures. They were not represented for perifused-islet experiments. Ant, antimycin; rot, rotenone.](zdb0030956550006){#f6}
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